Department of Surgery, Dartmouth-Hitchcock Medical Center, The Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
Ann Surg Oncol. 2020 Jan;27(1):45-53. doi: 10.1245/s10434-019-07752-7. Epub 2019 Aug 28.
Traditional measures of quality and effectiveness in surgical oncology have focused on morbidity, mortality, and when available, recurrence rates. Measuring patient-reported outcomes (PROs) has become more widely accepted during the last decade. This article reviews instruments commonly used in the surgical treatment of cancer patients to evaluate PROs. In addition, it discusses the linkage of PROs and health-related quality of life measures with traditional surgical complications and highlights future directions related to the expanding use of PROs in the surgical care of cancer patients.
传统的外科肿瘤学质量和效果衡量标准主要集中在发病率、死亡率以及在有条件的情况下,复发率上。在过去十年中,衡量患者报告的结果(PROs)已被更广泛地接受。本文回顾了常用于评估癌症患者 PROs 的外科治疗工具。此外,它还讨论了 PROs 和健康相关生活质量测量与传统手术并发症之间的联系,并强调了与在癌症患者的外科护理中扩大使用 PROs 相关的未来方向。